This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
EMD Millipore
other brands :
Oncogene Research Products, Calbiochem, Novagen, Merck, Upstate Biotechnology, Chemicon, LINCO, Novabiochem, Guava
product type :
antibody
product name :
Fusion Glycoprotein of Human parainfluenzavirus Type 3 Antibody, clone 9-4-3
catalog :
MAB10207
quantity :
100 µL
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
9-4-3
application :
immunocytochemistry
citations: 2
Reference |
---|
product information
Catalog Number :
MAB10207
Subcategory :
Infectious Diseases
Product Name :
Anti-Fusion Glycoprotein of Human parainfluenzavirus Type 3 Antibody, clone 9-4-3
Product Type :
Antibodies
Clonality :
Monoclonal Antibody
Gene ID :
P06828
Host Name :
Mouse
Antigen :
Fusion Glycoprotein of Human parainfluenzavirus Type 3
Clone :
9-4-3
Conjugate :
Ascites
Isotype :
IgG1
Product Description :
Anti-Fusion Glycoprotein of Human parainfluenzavirus Type 3 Antibody, clone 9-4-3
Background :
Human parainfluenza virus type 3 (PI3 virus) causes mild to severe respiratory tract infection in infants. PI3 virus is an enveloped RNA virus and possesses two glycoproteins, hemagglutinin-neuraminidase (HN) and fusion (F), at its external surface. These two glycoproteins are known to be responsible for initiation and progress of the infection process
ALT Names :
PI3
Immunogen :
Fusion (F) glycoprotein of human parainfluenzavirus type 3
Package Size :
100 µL
Uses :
Immunofluorescence
Storage :
1 year at -20°C from date of shipment
company information
EMD Millipore
290 Concord Road
Billerica, Massachusetts 01821
Billerica, Massachusetts 01821
bioscienceshelp@emdchemical.com
https://www.emdmillipore.com888-854-3417
headquarters: United States
EMD Millipore is the Life Science division of Merck KGaA of Darmstadt, Germany
Hundreds of New Antibodies in the areas of:
View all the new antibodies at www.emdmillipore.com.
Hundreds of New Antibodies in the areas of:
|
|
questions and comments